Inactive

The National Center for Advancing Translational Sciences (NCATS) is seeking to acquire a warranty for Molecular Devices' FLIPR Tetra high-throughput cellular screening systems and associated robotics.... The National Center for Advancing Translational Sciences (NCATS) is seeking to acquire a warranty for Molecular Devices' FLIPR Tetra high-throughput cellular screening systems and associated robotics. The instrument requires a maintenance agreement from the original vendor to include service coverage for the parts, labor, annual PM, and priority response. Molecular Devices' FLIPR Tetra high-throughput cellular screening systems addresses key technological needs for GPCR, ion channel and stem cell related projects, all of which have strong implications on the pain and opioid addiction fields of research. Additional information is available in the attached combined synopsis/solicitation.